About Medix Biotechnologies
Medix Biotechnologies is a company based in Santa Clara (United States) founded in 2023. It operates as a B2B. Medix Biotechnologies offers products and services including Hypersens™ RT-PCR Kits, Antimicrobial Treatment Map Software, and Custom Assay Design Software. Medix Biotechnologies operates in a competitive market with competitors including Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Medix Biotechnologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medix Biotechnologies
Medix Biotechnologies offers a comprehensive portfolio of products and services, including Hypersens™ RT-PCR Kits, Antimicrobial Treatment Map Software, and Custom Assay Design Software.
AI-optimized kits for detecting multiple pathogens and resistance genes.
Software for mapping targeted antibiotic treatments based on detections.
AI-driven tool for creating assays to detect pathogens and genomic material.
Funding Insights of Medix Biotechnologies
Detailed funding history for Medix Biotechnologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medix Biotechnologies
Investment portfolio details for Medix Biotechnologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medix Biotechnologies
Detailed financials for Medix Biotechnologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medix Biotechnologies Comparisons
Peer comparison for Medix Biotechnologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medix Biotechnologies
Medix Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, MeMed, GenMark Diagnostics, Sunbird Bio and T2 Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| Locked | Locked | Locked |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
Detailed competitors of Medix Biotechnologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medix Biotechnologies
Complete news archive for Medix Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medix Biotechnologies
Medix Biotechnologies was founded in 2023.
Medix Biotechnologies is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Medix Biotechnologies focuses on AI-driven platforms for molecular diagnostics, offering products like Hypersens RT-PCR kits that detect multiple pathogens from a single sample. They use computational algorithms to innovate genomic data analysis, enabling precise and timely treatment. The company partners with diagnostic laboratories and OEMs for research and distribution. Based in Santa Clara, California, USA, they aim to reduce antimicrobial resistance through efficient testing.
Medix Biotechnologies's top competitors include Visby Medical, Inflammatix and MeMed.
Medix Biotechnologies offers Hypersens™ RT-PCR Kits, Antimicrobial Treatment Map Software, and Custom Assay Design Software.